Facing pressure from pharma, FDA delays off-label promotion rule

After pharmaceutical industry groups filed a petition against the FDA’s new off-label promotion rule, the federal watchdog agency said last week it would delay the rule’s implementation to March 19, 2018. The agency originally intended for the law to go into effect on March 21 this year.

The rule would expand the evidence that the FDA can use to claim that a drug has been misbranded, therefore restricting drugmakers’ off-label promotion of drugs.

Get the full story at our sister site, Drug Delivery Business News.

The post Facing pressure from pharma, FDA delays off-label promotion rule appeared first on MassDevice.

from MassDevice http://ift.tt/2mMM906